These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 7574768

  • 21. Antiestrogens sensitize human ovarian and lung carcinomas for lysis by autologous killer cells.
    Baral E, Nagy E, Krepart GV, Lotocki RJ, Unruh HW, Berczi I.
    Anticancer Res; 2000; 20(3B):2027-31. PubMed ID: 10928146
    [Abstract] [Full Text] [Related]

  • 22. [Clinical evaluation of intrapleural or peritoneal administration of lentinan and OK-432 for malignant effusion].
    Kawaoka T, Yoshino S, Hazama S, Tangoku A, Oka M.
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1562-5. PubMed ID: 14619464
    [Abstract] [Full Text] [Related]

  • 23. [Clinical evaluation of intrapleural or peritoneal repetitive administration of Lentinan and OK-432 for malignant effusion].
    Kawaoka T, Yoshino S, Kondo H, Yamamoto K, Hazama S, Oka M.
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1565-7. PubMed ID: 16315870
    [Abstract] [Full Text] [Related]

  • 24. [Adoptive immunotherapy in patients with multiple hepatic cancers using lymphokine activated killer cells (LAK) and interleukin-2].
    Kanai T, Monden M, Takeda T, Gotoh M, Sakon M, Umeshita K, Hasuike Y, Sakita I, Nakano H, Yoshida T.
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1457-60. PubMed ID: 8396896
    [Abstract] [Full Text] [Related]

  • 25. [Effect of intrapleural and/or intraperitoneal lentinan therapy on carcinomatous pleuritis and peritonitis with special reference to immunological evaluation].
    Yoshino S, Oka M, Hazama S, Suzuki T.
    Nihon Geka Hokan; 1989 May 01; 58(3):310-9. PubMed ID: 2619436
    [Abstract] [Full Text] [Related]

  • 26. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
    Barton DP, Blanchard DK, Duan C, Roberts WS, Cavanagh D, DeCesare S, Djeu JY.
    J Soc Gynecol Investig; 1995 May 01; 2(6):762-71. PubMed ID: 9420887
    [Abstract] [Full Text] [Related]

  • 27. Intracavitary beta-interferon for the management of pleural and/or abdominal effusions in patients with advanced cancer refractory to chemotherapy.
    Gebbia V, Russo A, Gebbia N, Valenza R, Testa A, Palmeri S, Rausa L.
    In Vivo; 1991 May 01; 5(6):579-81. PubMed ID: 1810442
    [Abstract] [Full Text] [Related]

  • 28. Augmentation of lymphokine-activated killer cell activity by lentinan.
    Tani M, Tanimura H, Yamaue H, Tsunoda T, Iwahashi M, Noguchi K, Tamai M, Hotta T, Mizobata S.
    Anticancer Res; 1993 May 01; 13(5C):1773-6. PubMed ID: 8267381
    [Abstract] [Full Text] [Related]

  • 29. Lentinan with S-1 and paclitaxel for gastric cancer chemotherapy improve patient quality of life.
    Kataoka H, Shimura T, Mizoshita T, Kubota E, Mori Y, Mizushima T, Wada T, Ogasawara N, Tanida S, Sasaki M, Togawa S, Sano H, Hirata Y, Ikai M, Mochizuki H, Seno K, Itoh S, Kawai T, Joh T.
    Hepatogastroenterology; 2009 May 01; 56(90):547-50. PubMed ID: 19579640
    [Abstract] [Full Text] [Related]

  • 30. Increased non-major histocompatibility complex-restricted lytic activity in melanoma patients vaccinated with cytokine gene-transfected autologous tumor cells.
    Möller P, Möller H, Sun Y, Dorbic T, Henz BM, Wittig B, Schadendorf D.
    Cancer Gene Ther; 2000 Jul 01; 7(7):976-84. PubMed ID: 10917199
    [Abstract] [Full Text] [Related]

  • 31. [Autologous tumor specific immunotherapy of refractory cancers with ex vivo-generated T cells stimulated by autologous tumor cell].
    Toh U, Yamana H, Kido K, Mine T, Fujii T, Horiuchi H, Sasatomi T, Ishibashi N, Yutani S, Fujita H, Shirouzu K.
    Gan To Kagaku Ryoho; 2003 Oct 01; 30(11):1566-70. PubMed ID: 14619465
    [Abstract] [Full Text] [Related]

  • 32. The intrapleural administration of recombinant interleukin-2 (rIL-2) to patients with malignant pleural effusion: clinical trials.
    Suzuki H, Abo S, Kitamura M, Hashimoto M, Izumi K.
    Surg Today; 1993 Oct 01; 23(12):1053-9. PubMed ID: 8118118
    [Abstract] [Full Text] [Related]

  • 33. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD.
    Clin Cancer Res; 2000 Jun 01; 6(6):2268-78. PubMed ID: 10873077
    [Abstract] [Full Text] [Related]

  • 34. [Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer].
    Taguchi T.
    Gan To Kagaku Ryoho; 1983 Feb 01; 10(2 Pt 2):387-93. PubMed ID: 6349538
    [Abstract] [Full Text] [Related]

  • 35. Tissue distribution and tumor localization of effector cells in adoptive immunotherapy of cancer.
    Basse PH.
    APMIS Suppl; 1995 Feb 01; 55():1-28. PubMed ID: 8534522
    [Abstract] [Full Text] [Related]

  • 36. Immunoregulatory effects of the antitumor polysaccharide lentinan on Th1/Th2 balance in patients with digestive cancers.
    Yoshino S, Tabata T, Hazama S, Iizuka N, Yamamoto K, Hirayama M, Tangoku A, Oka M.
    Anticancer Res; 2000 Feb 01; 20(6C):4707-11. PubMed ID: 11205205
    [Abstract] [Full Text] [Related]

  • 37. Induction of lymphokine-activated cytotoxic T lymphocytes stimulated by dendritic cells and autologous tumor from a patient with gastric cancer and their effects in vitro.
    Yoshikawa T, Yanoma S, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Noguchi Y.
    Hepatogastroenterology; 2005 Feb 01; 52(61):289-92. PubMed ID: 15783052
    [Abstract] [Full Text] [Related]

  • 38. Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey.
    Taguchi T.
    Cancer Detect Prev Suppl; 1987 Feb 01; 1():333-49. PubMed ID: 3121179
    [Abstract] [Full Text] [Related]

  • 39. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
    Perez-Soler R, Shin DM, Siddik ZH, Murphy WK, Huber M, Lee SJ, Khokhar AR, Hong WK.
    Clin Cancer Res; 1997 Mar 01; 3(3):373-9. PubMed ID: 9815694
    [Abstract] [Full Text] [Related]

  • 40. [Intrapleural administration with OK-432 and cultured autologous pleural effusion lymphocytes for breast cancer patients with malignant pleural effusions: analysis of 84 patients over a 14-year period].
    Kan N.
    Gan To Kagaku Ryoho; 1999 Oct 01; 26(12):1796-800. PubMed ID: 10560397
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.